Dr. Ruben Mesa, MD, director of the Mays Cancer Center, discusses the importance of developing racially inclusive clinical trials in myeloproliferative neoplasms (MPNs). Watch the interview.

Dear Mays Cancer Center community, I’m delighted to share with you that as of today, Aug. 13, 2020, the Mays Cancer Center has officially been renewed as a National Cancer Institute-designated cancer center for the next five years. After a highly competitive process, the National Cancer Institute empowers us to continue our mission to Decrease […]

Dr. Ruben Mesa, MD, director of the Mays Cancer Center, says racial and ethnic disparities in cancer clinical trials impact diagnostics and treatment of minority populations and explains the importance of diversity in clinical trials. Read the story.

Dr. Ruben Mesa, MD, director of the Mays Cancer Center, discusses the racial and ethnic disparities in cancer clinical trials and the efforts being made to increase diversity in clinical trials. Read the story.

Ruben A. Mesa, MD, director of the Mays Cancer Center, discusses mitigating racial disparities in myeloproliferative neoplasm (MPN) clinical trials. Watch the interview.